Innerva Pharmaceuticals
About:
Innerva Pharmaceuticals develops novel treatment for Ocular Surface Pain.
Website: http://www.innervapharma.com/
Top Investors: Inveready
Description:
Innerva Pharmaceuticals is an ophthalmic pharmaceutical company that is working on developing a new treatment for Ocular Surface Pain. It is dedicated to the research and development of new drugs for the treatment of ocular pain that accompanies various ocular surface diseases, such as dry eye, post-surgical ocular pain and neuropathic ocular pain. .
Total Funding Amount:
2.3M EUR
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2021-01-01
Contact Email:
ptresserras(AT)innervapharma.com
Founders:
Number of Employees:
Last Funding Date:
2022-10-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai